4.7 Article

Discovery and In Vivo Proof of Concept of a Highly Potent DualInhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase forthe Treatment of Alzheimer's Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Medicinal

7-Amidocoumarins as Multitarget Agents against Neurodegenerative Diseases: Substitution Pattern Modulation

Fernanda Rodriguez-Enriquez et al.

Summary: The study investigated the potential of 7-amidocoumarins as multitarget agents against Parkinson's and Alzheimer's diseases by modulating substitution patterns within the scaffold. Five compounds were potent and selective hMAO-B inhibitors, while six showed inhibitory activity of hMAO-A. The compounds also demonstrated neurotoxicity and neuroprotection, supporting their safety profile.

CHEMMEDCHEM (2021)

Review Neurosciences

Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease

Gabriella Marucci et al.

Summary: Alzheimer's disease is characterized by cognitive decline and behavioral manifestations, with the most common treatment being cholinesterase inhibitors. Despite their limited efficacy and gastrointestinal side effects, ChE-Is remain a pharmacotherapeutic resource for AD treatment. Investigating combinations with other drug classes may offer renewed interest in the use of ChE-Is for adult-onset dementia disorders.

NEUROPHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study

Martin Kratky et al.

Summary: In this study, a series of compounds with potential cholinesterases and monoamine oxidases inhibitory activity were synthesized. Some compounds exhibited good dual inhibition, demonstrating their potential in multi-target-directed ligand design.

BIOORGANIC CHEMISTRY (2021)

Article Chemistry, Medicinal

Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents

Min Wang et al.

Summary: The study focused on the design and synthesis of novel compounds with multitarget-directed ligand-based strategy for Alzheimer's disease. Compound 10b demonstrated excellent potency in GSK-3 beta inhibition, anti-neuroinflammatory effects, and glucose consumption, as well as neuroprotective properties. In vivo experiments showed that compound 10b improved cognitive impairment in mouse models, indicating its potential as a multifunctional lead compound.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products

Cheng-Peng Sun et al.

Summary: Soluble epoxide hydrolase (sEH) is a vital protein that plays a crucial role in cardiovascular, central nervous system, and metabolic diseases. Inhibiting sEH may offer potential solutions for the treatment of these diseases.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice

Elisabet Viayna et al.

Summary: By combining the scaffolds of the cholinesterase inhibitor huprine Y and the antioxidant capsaicin, compounds with nanomolar potencies towards AChE and BChE were created, demonstrating potential therapeutic effects for Alzheimer's disease.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT6 receptor with anti-aggregation properties against amyloid-beta and tau

Tomasz Wichur et al.

Summary: The study identified compounds 17 and 35 as potential treatments for Alzheimer's disease, acting as 5-HT6R antagonists and cholinesterase inhibitors with different mechanisms of enzyme inhibition. In vitro experiments demonstrated their pharmacological characteristics and metabolic stability.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects

Caterina Pont et al.

Summary: Through virtual screening, a lead compound with potential anti-AD activity has been identified, showing activity against BACE-1 and cholinesterases, while also playing a role in inhibiting Ab42 and tau aggregation, improving memory, and increasing synaptic protein levels.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer's Disease

Benjamin Guieu et al.

Summary: Alzheimer's disease is a multifactorial neurodegenerative disease, and using Multi-Target Directed Ligands is considered convenient in targeting validated factors like acetylcholinesterase and Monoamine Oxidase-B. Ladostigil, currently in clinical trials, shows promising results in inhibiting these factors. The synthesis of a compound, propargylaminodonepezil, showed inhibitory activities towards AChE and MAO-B.

MOLECULES (2021)

Article Biochemistry & Molecular Biology

Tacrine - Benzothiazoles: Novel class of potential multitarget anti-Alzheimets drugs dealing with cholinergic, amyloid and mitochondrial systems

Eugenie Nepovimova et al.

Summary: The series of tacrine-benzothiazole hybrids show promising anti-AChE properties and capability to block Aβ aggregation, with the most potent derivative being 10w that exhibits highly selective inhibition of AChE. Moreover, 10w also demonstrates strong inhibitory effects against ABAD activity.

BIOORGANIC CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

(±)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease

Lhassane Ismaili et al.

Summary: Multitarget-directed ligands (MTDLs) are a promising therapeutic strategy for Alzheimer's disease, with compounds like (+/-)-BIGI-3h showing balanced activities towards multiple AD targets. In vitro studies demonstrated antioxidant effects, brain penetration, and inhibition of protein aggregation, while in vivo studies showed cognitive improvement.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Chemistry, Multidisciplinary

Structure-Guided Design of G-Protein-Coupled Receptor Polypharmacology

Stefanie Kampen et al.

Summary: This study presents a structure-based strategy to design compounds with dual-target properties, which can both antagonize the A(2A) adenosine receptor and activate the D-2 dopamine receptor, showing promising potential as anti-parkinson drugs.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Chemistry, Medicinal

Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease

Michele Rossi et al.

Summary: Alzheimer's disease's multifactorial nature hinders effective drug development. A research team developed sustainable multi-target-directed ligands based on inexpensive cashew nutshell liquid, selecting compounds through cell toxicity and enzymatic studies to confirm their activity.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

From the Design to the In Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis

Sandra Codony et al.

Summary: Inhibition of soluble epoxide hydrolase (sEH) has shown efficacy in treating inflammatory and pain-related diseases. New sEH inhibitors with benzohomoadamantane scaffold demonstrated excellent inhibitory activities, showing potential for the design of novel sEHIs. Molecular dynamics simulations and in vivo studies in a murine model of acute pancreatitis supported the promising efficacy of these compounds in improving health status and reducing pancreatic damage.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Multidisciplinary

From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein-Templated Synthesis

Vanesa Nozal et al.

Summary: The study aims to develop multitarget directed ligands for neurodegenerative disorders, successfully obtaining well-balanced MTDLs with in vitro activity in three targets, demonstrating potential in treating AD.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Biochemistry & Molecular Biology

Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment

Galina F. Makhaeva et al.

Summary: Eleven new amiridine-piperazine hybrids were synthesized as potential agents for Alzheimer's disease treatment, displaying mixed-type reversible inhibition of AChE and BChE. Compounds with para-substituted aromatic moieties exhibited the highest anti-AChE activity, while compounds with cyclohexyl and 2-MeO-Ph groups showed appreciable antioxidant capability. The conjugates showed low activity against carboxylesterase and exhibited potential to block AChE-induced beta-amyloid aggregation.

BIOORGANIC CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxa-diazole as multitargeted hybrids for the treatment of Alzheimer's disease

Priyanka Kumari Choubey et al.

Summary: Molecules 8f and 12f exhibited significant inhibition against several key enzymes, with potential for Aβ aggregate disassembly and neuroprotection on SHSY-5Y cell lines.

BIOORGANIC CHEMISTRY (2021)

Review Pharmacology & Pharmacy

Computational insights into the known inhibitors of human soluble epoxide hydrolase

Maria Bzowka et al.

Summary: Inhibiting human soluble epoxide hydrolase (hsEH) is beneficial for anti-inflammatory effects by overcoming the conversion of EETs into nonbioactive molecules. Previous research has made progress in hsEH inhibitors, with crystallizing a hundred hsEH-ligand complexes and utilizing computationally driven strategies to offer insights for future drug design.

DRUG DISCOVERY TODAY (2021)

Article Chemistry, Medicinal

Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse Model

Matthias Scheiner et al.

Summary: A series of multitarget-directed ligands (MTDLs) were designed by functionalizing a pseudo-irreversible butyrylcholinesterase (BChE) inhibitor, showing retention of antioxidative properties in vitro and maintenance of hBChE inhibition in the submicromolar range. The most promising compound demonstrated high efficacy in a pharmacological Alzheimer's disease (AD) mouse model.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Discovery of Novel Tacrine-Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer's Disease

Hong Yao et al.

Summary: A series of novel tacrine-pyrimidone hybrids showed significant inhibitory activities against AChE and GSK-3. The optimal compound 27g exhibited dual AChE/GSK-3 inhibition, cognitive improvement, and neuroprotection, making it a promising lead for AD treatment.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist

Xiangqian Li et al.

Summary: The development of multitarget-directed ligands (MTDLs) is a widely focused research topic, but rational design remains a challenge. Strategies for designing MTDLs include merging lead compounds with similar functional groups, fusing key pharmacophores directly, and using the linked-pharmacophore strategy. The pharmacophores of second targets should not affect the binding mode of the original ones, and the inhibitory activities of the two targets need to be adjusted.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Clinical Neurology

Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer's disease

Kamil Borkowski et al.

Summary: This study analyzed lipid mediators in plasma and cerebrospinal fluid of individuals with Alzheimer's disease and healthy controls, finding elevated cytochrome P450/soluble epoxide hydrolase pathway components and decreased fatty acid ethanolamides in Alzheimer's disease patients. The results suggest potential therapeutic benefits of targeting both metabolic pathways for Alzheimer's disease treatment.

ALZHEIMERS RESEARCH & THERAPY (2021)

Article Pharmacology & Pharmacy

A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice

Julia Companys-Alemany et al.

PHARMACEUTICS (2020)

Article Chemistry, Medicinal

Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6

F. Javier Perez-Areales et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Clinical Neurology

Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease

Christian Grinan-Ferre et al.

NEUROTHERAPEUTICS (2020)

Review Medicine, Research & Experimental

Eicosanoid blood vessel regulation in physiological and pathological states

John D. Imig

CLINICAL SCIENCE (2020)

Article Cell Biology

An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease

Anamitra Ghosh et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Chemistry, Medicinal

Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds

Ewgenij Proschak et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activity

Kerstin Hiesinger et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2019)

Article Biochemistry & Molecular Biology

A new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies

Oksana Gerlits et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2019)

Article Chemistry, Medicinal

A novel class of multitarget anti-Alzheimer benzohomoadamantane- chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors

F. Javier Perez-Areales et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Pharmacology & Pharmacy

Metabolic stability and its role in the discovery of new chemical entities

Karolina Sloczynska et al.

ACTA PHARMACEUTICA (2019)

Review Neurosciences

Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model

Christian Grinan-Ferre et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Article Chemistry, Multidisciplinary

Dynamic undocking and the quasi-bound state as tools for drug discovery

Sergio Ruiz-Carmona et al.

NATURE CHEMISTRY (2017)

Article Chemistry, Medicinal

A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis

Jurema Schmidt et al.

JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Chemistry, Medicinal

Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends

Sergey O. Bachurin et al.

MEDICINAL RESEARCH REVIEWS (2017)

Review Clinical Neurology

Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease

Sultan Darvesh

CURRENT ALZHEIMER RESEARCH (2016)

Article Chemistry, Physical

ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB

James A. Maier et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)

Article Chemistry, Medicinal

Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro Target Residence Time and in Vivo Efficacy

Kin Sing Stephen Lee et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Biochemical Research Methods

rDock: A Fast, Versatile and Open Source Program for Docking Ligands to Proteins and Nucleic Acids

Sergio Ruiz-Carmona et al.

PLOS COMPUTATIONAL BIOLOGY (2014)

Article Pharmacology & Pharmacy

Comparative efficacy of 3 soluble epoxide hydrolase inhibitors in rat neuropathic and inflammatory pain models

Karen Wagner et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2013)

Article Chemistry, Physical

PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data

Daniel R. Roe et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2013)

Article Chemistry, Physical

Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald

Romelia Salomon-Ferrer et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2013)

Article Biochemistry & Molecular Biology

The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease

John E. Morley et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)

Review Pharmacology & Pharmacy

The influence of lipophilicity in drug discovery and design

John A. Arnott et al.

EXPERT OPINION ON DRUG DISCOVERY (2012)

Article Chemistry, Physical

Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born

Andreas W. Goetz et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)

Review Physics, Multidisciplinary

SHAKE parallelization

R. Elber et al.

EUROPEAN PHYSICAL JOURNAL-SPECIAL TOPICS (2011)

Article Chemistry, Physical

PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions

Mats H. M. Olsson et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2011)

Article Biochemistry & Molecular Biology

Acetylcholinesterase: How is structure related to function?

Israel Silman et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2008)

Review Chemistry, Medicinal

Multi-target-directed ligands to combat neurodegenerative diseases

Andrea Cavalli et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Article Chemistry, Medicinal

The physicochemical challenges of designing multiple ligands

Richard Morphy et al.

JOURNAL OF MEDICINAL CHEMISTRY (2006)

Article Biochemistry & Molecular Biology

Validation of an empirical RNA-ligand scoring function for fast flexible docking using RiboDock®

SD Morley et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2004)

Article Multidisciplinary Sciences

Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation

Y Bourne et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Chemistry, Multidisciplinary

Development and testing of a general amber force field

JM Wang et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)

Article Chemistry, Physical

Self-guided Langevin dynamics simulation method

XW Wu et al.

CHEMICAL PHYSICS LETTERS (2003)

Article Chemistry, Medicinal

High throughput artificial membrane permeability assay for blood-brain barrier

L Di et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)

Article Biochemistry & Molecular Biology

Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site

Y Bourne et al.

EMBO JOURNAL (2003)

Article Chemistry, Multidisciplinary

Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation

A Jakalian et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2002)

Article Biochemistry & Molecular Biology

Inhibition of acetylcholinesterase from Electrophorus electricus (L.) by tricyclic antidepressants

N Nunes-Tavares et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2002)

Article Chemistry, Physical

Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K

P Mark et al.

JOURNAL OF PHYSICAL CHEMISTRY A (2001)

Article Chemistry, Organic

A facile synthesis of bis-tacrine isosteres

MK Hu et al.

TETRAHEDRON LETTERS (2000)

Article Biochemistry & Molecular Biology

The Protein Data Bank

HM Berman et al.

NUCLEIC ACIDS RESEARCH (2000)